Based on these results, compared to tumor tissues, PDLIM2 is highly expressed in normal tissues from patients with BLCA, cervical squamous cell carcinoma, esophageal carcinoma, kidney chromophobe, KIRP, LUAD, LUSC, rectum adenocarcinoma, skin cutaneous melanoma, uterine corpus endometrial carcinoma, and uterine carcinosarcoma. Here, PDLIM2 is linked to uterine carcinosarcoma.